DB05439ExperimentalVaccines
Lipids promote the fusion of liposomes to cells. Eladem (IDD-1) is a therapeutic vaccine consisting of dendritophages that are loaded in vitro with tumor antigens and then reinjected into the... As with other monoclonal antibodies, this process stimulates an immune response to a particular disease-related antigen.
- Mechanism
- Curator reviewed
The lipid promotes fusion of liposomes to cells. Specifically, IDD-1 targets tumor cells by coupling dendritophages with tumor antigens obtained from the patient.
- Primary indication
- Investigated for use/treatment in prostate cancer.Curator reviewed
Which companies are running trials of IDD-1, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account